Argenx (ARGX) Competitor Comparison
We are evaluating the key criteria listed to compare Argenx (ARGX) against its competitors in the Biotechnology industry.
Market Capitalization
5 / 368Gross Profits
268 / 278Total Revenue
18 / 300EBITDA
292 / 337Free Cashflow
0 / 352Quick Ratio
0 / 357Earnings per Share
108 / 359Dividend yield
0 / 6Total Cash
9 / 358Performance 3 years
48 / 368Performance 5 years
25 / 368Performance 10 years
1 / 368Linearity 3 years
234 / 368Linearity 5 years
351 / 368Linearity 10 years
368 / 368Total Rank
292 / 368Dividend Rank
361 / 368Valuation Rank
279 / 368Piotroski Rank
351 / 368Muliplier Rank
278 / 368Piotroski Rank - ARGX ranking 351 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.